Age Inhibitors

Abstract

The invention relates to a compound having general formula I, wherein: X represents CH<sub>2</sub>, C═O, C═S or CHOH, R<sub>1 </sub>represents an amino acid optionally substituted by one or more halogen atoms, or by one or more CF<sub>3 </sub>groups and n=0.1 or 2, or R<sub>1 </sub>represents a peptide containing two amino acids, each amino acid being optionally substituted by one or more halogen atoms, or by one or more CF<sub>3 </sub>groups and n=0 or 1, or XR<sub>1 </sub>represent PO<sub>3</sub>H or SO<sub>3</sub>H and n=0.1 or 2; R<sub>2 </sub>represents H, XR1, an alkyl group at C<sub>1</sub>-C<sub>6</sub>, an aralkyl group at C<sub>1</sub>-C<sub>6 </sub>or an aryl group, whereby the alkyl, aralkyl and aryl groups can be substituted by an amine NH<sub>2</sub>, a carboxylic group COOH, one or more halogen atoms.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 6, 2016
  • Application: Apr 2, 2012
    US US 201213437491 A
  • Priority: Apr 2, 2012
    US US 201213437491 A
  • Priority: Dec 5, 2007
    US US 90976107 A
  • Priority: Mar 30, 2006
    EP EP 2006061191 W
  • Priority: Mar 31, 2005
    FR FR 0503176 A

Download Citation


Sign in to the Lens

Feedback